Of the 19 paired cancers from which tissue was available for immunohistochemical analysis, five patients demonstrated MSI-H with loss of a concordant MMR genes and one demonstrated concordant loss of MLH1 expression in MSI-H and MSI-L cancers, suggesting that 31% of patients might have HNPCC. This evidence concerns the gene MRC1 and cancer.